Connect with us

Technology

EMERGE Reports Strong Q2 2026 Results

Published

on

Q2 revenue increased by 7.4% to $9.1M (9th consecutive quarter of YoY growth)Q2 Adj. EBITDA(1) improved by 7.3% to $1M (7th consecutive quarter of positive Adj. EBITDA) Cash grew YoY to $4.8M from $3.5M Q3 2025 Outlook: Continued revenue growth, improved gross margins, and positive Adj. EBITDA(1) expected 

TORONTO, Aug. 27, 2026 /CNW/ — EMERGE Commerce Ltd. (TSXV: ECOM) (“EMERGE” or the “Company”), an acquirer and operator of profitable e-commerce brands and technologies, today announced its financial results for the three months ended June 30, 2026. Copies of the interim Financial Statements and MD&A are available on the Company’s profile on SEDAR at www.sedar.com.

Q2 2026 Financial Highlights

For the second quarter of 2026, compared to the second quarter of 2025:

Q2 Revenue grew to $9.11M vs. $8.48M, an increase of 7.4% YoY, marking the 9th consecutive quarter of YoY revenue growth Q2 Gross profit grew to $3.55M vs. $3.09M, an increase of 14.8% YoYQ2 Gross margin increased to 39.0% vs. 36.5%Q2 Adj. EBITDA(1) improved to $1.03M vs. $0.96M, an increase of 7.3%, marking the 7th consecutive quarter of positive Adj. EBITDA(1)  Positive Net Income of $200K, approximately in line with prior periodCash position grew to $4.8M (June 30, 2026) vs. $3.5M (June 30, 2025), an increase of $1.3M YoY

Viral Loops was acquired on March 10, 2026. Q2 was Viral Loops’ first full quarter under EMERGE ownership.

Ghassan Halazon, Founder and CEO, EMERGE, “Q2 was our strongest quarter in years, across both revenue and Adjusted EBITDA(1), with positive cash flow generation on full display. The 2026 golf season launched with strength, while Viral Loops contributed meaningfully to our improved gross margins and positive cash flow in its first full quarter under EMERGE. Importantly, all three of our verticals drove positive Adjusted EBITDA(1). Q2 also provides a more representative view of the underlying business, with T2G having been acquired in early April 2025. We are especially pleased that the business achieved positive cash flow overall in both Q2 and year-to-date, as we continue to build a stronger, more durable EMERGE.”

Outlook

For Q3 2026, EMERGE expects to deliver another quarter of revenue growth and positive Adjusted EBITDA(1).

Management anticipates that the year-over-year gross margin improvements achieved in Q2 2026 to continue in Q3, in part because of the higher margins contributed by Viral Loops, in addition to the conclusion of the fair value of inventory accounting at T2G that adversely impacted EMERGE’s gross margins for most of 2025.

The Company continues to make targeted investments across its portfolio, including at the HQ level, to support current and future growth, both organic and inorganic.

Q3 is a seasonally strong quarter for the golf business, particularly Tee 2 Green (“T2G”), while it is generally a slower period for truLOCAL during the summer holiday period. Seasonality at Viral Loops is less pronounced.

Debt Refinancing

EMERGE is making meaningful progress toward refinancing its senior debt, which remains one of our key priorities. Management is increasingly encouraged by the developments to date and we believe the significantly improved financial profile of the business puts the Company in a strong position to secure a materially lower-cost, longer-term financing facility. We view this as an important step in further strengthening our balance sheet and supporting EMERGE’s long-term growth objectives.

Top Priorities

The Company’s top priorities in the near-term are to i) drive organic growth, ii) extract synergies and savings to improve profitability, iii) explore avenues to enhance cash flow and reduce interest expense; and iv) explore accretive strategic/ tuck-in acquisition opportunities.

Conference Call

Management will host a conference call on Thursday, August 27 at 9:00 am ET to discuss its second quarter results. To access the conference call, please dial (416) 945-7677 or (888) 699-1199 and provide conference ID 99792.

Alternatively, the conference call can be accessed online at: https://app.webinar.net/DA8mBZqykrg.

Selected Financial Highlights

The tables below set out selected financial information and should be read in conjunction with the Company’s consolidated financial statements and MD&A for the three and six months ended June 30, 2026, which are available on SEDAR.

Selected Financial Information

The following financial information has been summarized from the Company’s unaudited condensed consolidated interim financial statements (excluding GMS and Adjusted EBITDA):

Three months ended June 30,

Six months ended June 30,

2026

$

2025

$

2026

2025

Gross Merchandise Sales

11,817,489

11,441,510

20,308,176

19,450,080

Total revenue

9,109,675

8,480,847

15,016,925

13,509,805

Adjusted EBITDA

1,030,934

958,016

1,153,174

990,315

Net loss from continuing operations

199,662

201,031

74,188

179,422

Net income

199,662

200,086

74,188

603,206

Basic and diluted loss per share from continuing operations

0.0011

0.00141

0.0004

0.00127

Total assets

13,707,680

10,625,159

13,707,680

10,625,159

Long-term liabilities

7,503,359

9,463,464

7,503,359

9,463,464

The following table presents Adjusted EBITDA for the three and six months ended June 30, 2026, and the Adjusted EBITDA loss for the three and six months ended June 30, 2025, along with a reconciliation of the Company’s reported results to its adjusted measures.

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

Net income

199,662

200,086

74,188

603,206

Add back:

Finance costs

433,781

369,681

799,533

623,908

Income taxes (recovery)

180,121

108,915

207,720

189,462

Amortization

106,392

51,669

183,311

104,447

EBITDA

919,956

730,351

1,264,752

1,521,023

Share-based compensation

32,400

63,379

64,800

121,524

Transaction cost

30,852

16,259

69,458

29,217

Foreign exchange and other losses (gains)

5,891

(234,772)

(68,078)

(639,519)

Gain on debt modification

–

–

(259,581)

–

Fair value adjustment to inventory acquired1

41,835

381,854

81,823

381,854

Net loss (income) from discontinued operations

–

945

–

(423,784)

Adjusted EBITDA

1,030,934

958,016

1,153,174

990,315

The following table highlights GMS for the three and six months ended June 30, 2026 and 2025, and a reconciliation of the Company’s reported results to its adjusted measures.

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

Revenue

9,109,675

8,480,847

15,016,925

13,509,805

Adjusted for:

Merchant costs deducted from net revenue

2,430,664

2,888,023

5,618,150

6,669,701

Deferred revenue and other adjustments to revenue recognized

336,954

157,609

(315,160)

(602,673)

Advertising revenue

(59,804)

(84,969)

(11,739)

(126,753)

GMS

11,817,489

11,441,510

20,308,176

19,450,080

About EMERGE

EMERGE Commerce (TSXV: ECOM) is a disciplined acquirer and operator of profitable e-commerce brands and technologies across Direct-to Consumer (“D2C”) and Business-to-Business (“B2B”) segments. Our D2C portfolio spans our Grocery and Golf verticals. truLOCAL is our flagship Canadian meat and seafood subscription service. Our Golf vertical includes UnderPar (discounted golf experiences), JustGolfStuff and Tee 2 Green (discounted apparel and equipment). EMERGE B2B houses Viral Loops, our referral marketing platform.  

Follow EMERGE:
LinkedIn | X | Instagram | Facebook

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

(1) Non-GAAP Measures

This press release makes reference to certain non-GAAP measures. These non-GAAP measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing a further understanding of results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the financial information of the Company reported under IFRS. Gross Merchandise Sales (“GMS”), EBITDA, and Adjusted EBITDA should not be construed as alternatives to revenue or net income/loss determined in accordance with IFRS. GMS, EBITDA and Adjusted EBITDA do not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers.

GMS as defined by management is the total dollar value of customer purchases of goods and services, excluding applicable taxes and net of discounts and refunds. Management believes GMS provides a useful measure for the dollar volume of e-commerce transactions made through our platforms and an indicator for our business performance.

Earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA as defined by management means earnings before interest and financing costs, income taxes, depreciation and amortization, transaction costs, foreign exchange gains/losses, discontinued operations, fair value increments on inventory included in cost of sales, unrealized gains/losses on contingent consideration and share-based compensation. Management believes that Adjusted EBITDA is a useful measure because it provides information about the operating and financial performance of EMERGE and its ability to generate ongoing operating cash flow to fund future working capital needs and fund future capital expenditures or acquisitions.

A reconciliation of the adjusted measures is included in the Company’s management discussion & analysis for the three and six months ended June 30, 2026 in the section “Non-GAAP Financial Measures” available through SEDAR at www.sedar.com.

Notice regarding forward-looking statements

This press release may contain certain forward-looking information and statements (“forward-looking information”) within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information.  Actual results and developments may differ materially from those contemplated by these statements.  The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable).  Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company’s control, including the risk factors discussed in the Company’s MD&A and Annual Information Form which are incorporated herein by reference and are available through SEDAR at www.sedar.com. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. Unless otherwise noted, all amounts are in Canadian dollars.

On Behalf of the Board
Ghassan Halazon
Director, President, and CEO
EMERGE Commerce Ltd.

SOURCE Emerge Commerce Ltd.

Continue Reading

Technology

Werfen launches a campaign to thank healthcare professionals and laboratories as part of its 60-year celebrations

Published

on

By

Through the short film ‘Thank You,’ featuring real patients, the campaign highlights the impact of in vitro diagnostics (IVD), which plays a key role in 70% of medical decisions worldwide and is crucial to patient survival and quality of lifeThe launch coincides with the company’s 60th anniversary, consolidating a six-decade trajectory to international leadership across its five clinical areas of specialized diagnostics

BARCELONA, Spain, Nov. 12, 2026 /PRNewswire/ — In Vitro Diagnostics (IVD) plays a crucial role in life-saving clinical decisions. To recognize and thank the healthcare professionals and laboratory teams who make this possible every day, Werfen has launched the ‘Thank You’ initiative. Launched on the occasion of its 60th anniversary, this is the company’s first corporate brand campaign centered entirely on its purpose of advancing patient care by delivering trusted and innovative specialized diagnostics.

Currently, IVD influences around 70% of clinical decisions worldwide, ranging from confirming compatibility in a kidney transplant to detecting chronic disease or monitoring patients during highly complex cardiac surgery. However, this analytical work largely takes place behind the scenes.

The central element in the campaign is a documentary short film, available at https://www.werfen.com/thankyou. With it, Werfen seeks to highlight the direct impact of having reliable and timely data, at the time of diagnosis and in the continuous management of diseases and people’s quality of life, focusing on improving patient outcomes through diagnostic precision.

The voice of patients and the true significance of diagnostics

The campaign gathers stories from real patients who have gone through complex health processes. Through their stories, patients express their gratitude to the healthcare professionals who interpreted their test results and provided the necessary clarity to determine the appropriate therapeutic path to manage their health.

Developed in collaboration with patient associations and non-profit organizations, the initiative gives visibility to the relevance of diagnostics in more than a dozen pathologies such as lupus, thalassemia, hemophilia, thrombosis episodes, rheumatoid arthritis, complex cardiac surgery, or kidney and liver transplants. All of them are severe medical conditions that represent Werfen’s five highly specialized clinical areas: Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant.

In the words of Alejandro Risso, CEO of Werfen: “Sixty years ago, Werfen was born with a calling to stand alongside healthcare professionals in moments that mark a before and after in patients’ lives. Our responsibility is to provide maximum analytical precision so that professionals can make decisions with total confidence when it matters most.” To this, he adds: “Behind every diagnosis there is knowledge, experience, precision and, above all, people committed to improving and saving lives. With this campaign we want to bring these professionals to the forefront and thank them for a work that, after 60 years, continues to give meaning to ours.”

Six decades of commitment to specialized diagnostics

The campaign launch takes place during the company’s 60-year anniversary. Founded in Barcelona in 1966, Werfen has evolved to establish itself as a multinational group specialized in IVD, with presence in more than 30 countries, as well as its own R&D capacity and production centers in Europe and the United States.

Throughout this time, the company has strengthened its international presence through direct commercial expansion in key markets such as the United States and China, coupled with the progressive integration of specialized firms in its different clinical areas. This process culminated in 2024 with the strategic decision to concentrate all its resources and research on in vitro diagnostics, thereby reaffirming its commitment to continue providing greater certainty to the scientific and medical community.

Innovation has been one of Werfen’s pillars throughout its 60-year history. As a result of this commitment, in 2025 the company allocated 190 million euros to research and development to continue driving advances in the science of in vitro diagnostics.

In a field where scientific rigor, clinical relevance, and reliability are fundamental, Werfen combines innovation, experience, and talent to offer more effective diagnostics that help laboratories, hospitals, doctors, and healthcare professionals make better clinical decisions and improve people’s quality of life.

About Werfen

Founded in 1966, Werfen is a worldwide developer, manufacturer, and distributor of specialized diagnostic instruments, related reagents, automation workcells, and data management solutions for use primarily in hospitals and independent clinical laboratories. The company’s business lines include Coagulation, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. With a workforce of over 7,130 people, Werfen operates directly in more than 30 countries and in over 100 territories through distributors. For more information, visit werfen.com.

Legal Disclaimer 

This document contains forward-looking statements regarding our future business, financial data, and future events related to Werfen that may constitute forward-looking estimates. These estimates can be identified by words such as “expectation,” “forward-looking,” “anticipation,” “intention,” “plan,” “belief,” “seek,” “estimate,” “future,” “project,” or words of similar meaning. We may also make forward-looking estimates in other reports, presentations, and press releases. Additionally, our representatives may occasionally make oral statements with forward-looking estimates. These estimates are based on our current expectations and certain assumptions, many of which are beyond the corporation’s control and are subject to a series of risks and uncertainties. In the event that any of such risks or uncertainties materialize or underlying expectations fail to occur, Werfen’s results, performance, or achievements could vary substantially (positively or negatively) from those explicitly or implicitly described in the relevant forward-looking estimate. Werfen assumes no obligation to revise or update any forward-looking estimates previously made.

SOURCE Werfen

Continue Reading

Technology

Robo.ai to Advance Its Middle East Public Safety Strategy at World Police Summit 2026

Published

on

By

Subsidiaries ALIF Holding and Neurovia AI to present visual data technology and outline plans for maritime systems and advanced materials at Stand AH5D

DUBAI, UAE, Nov. 12, 2026 /PRNewswire/ — Robo.ai Inc. (Nasdaq: AIIO) (“Robo.ai” or the “Company”) today announced that its controlled subsidiary ALIF Holding, an Abu Dhabi-based industrial group, together with Neurovia AI, another subsidiary of the Company, will participate in the World Police Summit on November 16–18, 2026, at the Dubai World Trade Centre. Participation in the Summit supports the Company’s strategy of bringing AI infrastructure and local industrial capabilities to government, public safety and mission-critical sectors in the UAE and wider Middle East.

Hosted by Dubai Police and organized by DXB LIVE, the Summit is a major Middle East platform that brings together international law enforcement leaders, public safety decision-makers and technology companies. Its fifth edition, themed “Connected for Impact,” offers Robo.ai a focused opportunity to engage with prospective customers and technology partners on their operational needs.

At Stand AH5D, Neurovia AI will present NeuroStream™, its visual data optimization platform designed to reduce video storage and transmission requirements while preserving information needed for downstream applications. In a previously reported demonstration, a 12.15 GB, 4K video file was reduced to 421 MB, a decrease of more than 96%. This result reflects a specific demonstration; actual performance and benefits depend on deployment conditions and use-case validation.

ALIF Holding will also outline plans for intelligent maritime systems for ports, coastlines and critical facilities through the proposed ALIF Maritec, and for carbon fiber materials and UAE manufacturing capabilities through the proposed ALIF Composites. Together, these initiatives reflect Robo.ai’s strategy of connecting efficient AI data infrastructure with intelligent systems and local industrial development.

This approach aligns with the UAE National Strategy for Artificial Intelligence 2031 and the technology-enabled public safety ambitions of “We the UAE 2031.” At the Summit, Robo.ai aims to deepen customer engagement and develop partnerships that can support commercial applications and long-term business growth.

About ALIF Holding

ALIF Holding is Robo.ai’s Abu Dhabi-based industrial group, focused on intelligent software, intelligent equipment and the development of local industrial capabilities. Through international technology collaboration and local integration, it aims to develop intelligent systems and products for governments, critical infrastructure and industrial customers.

About Neurovia AI

Neurovia AI is an Abu Dhabi-headquartered artificial intelligence infrastructure and visual data processing company, operating as a wholly owned subsidiary of Robo.ai Inc. (Nasdaq: AIIO).Through its flagship platform, NeuroStream™, the company develops intelligent data optimization solutions designed to reduce infrastructure demands while supporting efficient, secure and scalable AI applications.Neurovia AI serves the evolving needs of government, enterprise and data-intensive industries, advancing its vision of scaling sustainable AI infrastructure.

About Robo.ai Inc.

Robo.ai Inc. (Nasdaq: AIIO), headquartered in Dubai, United Arab Emirates, is a Nasdaq-listed technology group building intelligent infrastructure across four platforms: artificial intelligence; robotics and smart mobility; advanced manufacturing; and digital assets and capital. Its industrial group, ALIF Holding, is dedicated to building intelligent industries through the development, integration and manufacturing of AI systems, serving government, public sector and mission-critical domains. Through its subsidiary Neurovia AI, the Company develops AI software and visual data infrastructure. Quantum Core Capital (“QC Capital”), its AI-powered deep-tech holding and venture-building platform, incubates, invests in and operates businesses across artificial intelligence, robotics, digital infrastructure and the next-generation digital economy.

Forward-Looking Statements

This release includes forward-looking statements under the U.S. Private Securities Litigation Reform Act of 1995 concerning exhibition plans, technology benefits, proposed projects, local manufacturing, partnerships and business growth. These statements reflect current expectations and are not guarantees of future performance. Actual outcomes may differ materially due to technology validation and commercialization, customer demand, competition, funding, project formation, permits, equipment, site readiness and execution risks, as well as the Company’s financial condition and other risks described in its SEC filings. Proposed projects remain subject to development and operational readiness. These statements speak only as of the date of this release, and, except as required by applicable law, Robo.ai undertakes no obligation to update or revise them.

Media Contacts

ALIF Holding Corporate Communications
Email: info@alifholding.ai  |  Website: www.alifholding.ai

Neurovia AI | Marketing & Communications
Email: info@neuroviaai.com Website: www.neuroviaai.com

Robo.ai Inc. Corporate Communications
Email: pr@roboai.group  |  Website: www.roboai.group

View original content to download multimedia:https://www.prnewswire.com/news-releases/roboai-to-advance-its-middle-east-public-safety-strategy-at-world-police-summit-2026-302937724.html

SOURCE Robo.ai Inc.

Continue Reading

Technology

CodeWall Accelerates Expansion, Names Former Orca Security VP as CTO

Published

on

By

CodeWall is scaling its engineering team and autonomous attack platform with an ambition to make offensive security as fundamental as firewalls and endpoint protection.

LONDON, Nov. 12, 2026 /PRNewswire/ — CodeWall is accelerating its expansion to make autonomous offensive security a permanent enterprise capability. Following its $4 million pre-seed round, the company is scaling engineering and expanding what its autonomous attack agents can investigate, today announcing former Orca Security VP of Engineering Peter Spellward as Chief Technology Officer to lead that effort.

Spellward brings experience building security technology and the organisations behind it. At cloud security unicorn Orca Security, he served as VP of Engineering, led UK research and development and helped scale its engineering organisation. He also co-founded Innovode, whose technology was acquired by CloudLock, subsequently acquired by Cisco.

“AI is giving attackers extraordinary speed and reach. We’re building to put that advantage in the hands of enterprise security teams,” said Paul Price, founder and CEO of CodeWall. “We intend to move aggressively: hire exceptional engineers, expand what our agents can take on and bring this capability to more enterprises. Peter brings experience building the products and engineering organisations that make that expansion possible.”

Spellward leads technology strategy and engineering, with a focus on accelerating delivery, broadening platform coverage and strengthening how agents coordinate complex investigations.

“The engineering challenge is to turn sophisticated attacker behaviour into a capability enterprises can depend on continuously,” said Peter Spellward, CTO of CodeWall. “That means agents that can safely reason through unfamiliar systems, build on each other’s discoveries and produce evidence defenders can trust. We’re building the team and architecture to deliver that at scale.”

CodeWall’s agents investigate enterprise environments from an external attacker’s perspective. They share discoveries and follow weaknesses across connected systems to establish what could actually be compromised, supporting continued investigation and retesting as customer environments change.

The company is already working with large banks and fintech firms, including Axos Financial, to deliver autonomous offensive testing and verified evidence of exploitable attack paths.

“Every enterprise will have an attacker working for it. It will be as essential as a firewall or endpoint protection,” added Price. “We intend to make CodeWall the standard. That’s the scale we’re hiring for, building for and going after.”

To learn more or explore open roles, visit codewall.ai.

About CodeWall

CodeWall builds autonomous offensive security technology for enterprises. Its agents investigate externally accessible systems, trace exploitable weaknesses and provide verified evidence to help defenders address their exposure. The platform supports sustained adversarial testing within customer-defined guardrails.

Media Contact:
press@codewall.ai

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/codewall-accelerates-expansion-names-former-orca-security-vp-as-cto-302937370.html

Continue Reading

Trending